• Software
  • Services
    • Back
    • Consulting Services
      • Back
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Pro-ficiency | Adaptive Learning & Insights (ALI)
      • Medical Communications
    • Consulting Packages
      • Back
      • Consult + Coach
      • First-in-Human Simulator
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Back
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Back
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Back
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Back
    • Our Team
    • Leadership
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Back
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
  • Search
Simulations Plus logo
Simulations Plus logo

Simulations Plus

We Improve Health Through Innovative Solutions

  • Software
      • GastroPlus®
      • MonolixSuite™
      • ADMET Predictor®
      • DILIsym®
      • DDDPlus™
      • NAFLDsym®
      • MembranePlus™
      • Monolix®
      • OBESITYsym™
      • PKanalix®
      • Simulx®
      • IPFsym®
      • ILDsym®
      • RENAsym®
      • MedChem Designer™
      • Pro-ficiency Performance Management
      • Panorama KOL Insights Engine
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Quantitative Systems Pharmacology (QSP)
      • Physiologically Based Pharmacokinetic (PBPK) Software
      • Cheminformatics
      • Pro-ficiency | Adaptive Learning Insights (ALI)
      • Medical Communications
      • Software Packages
        • Consult + Coach
        • Plug ‘n’ Play
        • Pulmonary Package
        • First-in-Human Simulator
        • EvolvePK+
        • Liver Safety+
      • University+
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Pro-ficiency | Adaptive Learning & Insights (ALI)
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
Physiologically Based Pharmacokinetic (PBPK) Software
A hexagonal image featuring a digital network with interconnected points and lines in teal and blue over a dark background, symbolizing modeling and simulation data, ADMET, PBPK, QSP, & ClinPharm technology, and connectivity
1
A hexagonal image featuring a digital network with interconnected points and lines in teal and blue over a dark background, symbolizing modeling and simulation data, ADMET, PBPK, QSP, & ClinPharm technology, and connectivity
2
A digital Beagle in blue wireframe stands in a dark interface, echoing PBPK dog model
3
A person in a suit smiles at a laptop, using ADMET Predictor for pharmacokinetic analysis.
4
Two researchers use ADMET Predictor in a lab, analyzing chemical compound simulations.
  • Learn how your peers are using our software
  • Discuss my project needs
  • Check out the PBPK webinar playlist
  • GastroPlus® 9.9 Flyer
  • GastroPlus® Additional Dosage Routes Brochure
PBPK Predictions for Optimized Outcomes

When it comes to drug development, no one likes surprises.

You want to have the right data and insights at your fingertips to make informed decisions throughout the R&D process. Physiologically based pharmacokinetic (PBPK) modeling and simulation can help you anticipate likely outcomes for different scenarios, optimize your drug for the results you want, potentially waive expensive studies, and more.

Whether your in-house scientists are ready to leverage industry-leading PBPK software or you need PBPK/PBBM modeling support from our experts, we’re ready to help.

 

A DILIsym abstract diagram illustrates drug metabolism & PK pathways, featuring the liver & stages.
02. Software
PBPK Software
A neon green hexagon frames a human anatomy, with the "G+" for GastroPlus in white forefront.

Our flagship PBPK modeling and simulation platform, GastroPlus®, is built by scientists who understand both the complex biology, chemistry, and physiology interactions and advanced computer science required for reliable predictions. For more than 25 years, we’ve continued to refine our algorithms and incorporate the latest scientific research to ensure confidence in your simulation results.

GastroPlus is a flexible platform that can accommodate your program needs, even as they change. Our wide range of available modules can expand your team’s ability to model your drug’s behavior in various animal and human populations, disease states, via different administration routes, in combination with other therapies, and more.

03. Modules
Our GastroPlus Software Suite
  • GastroPlus®
    GastroPlus®
    PBBM/PBPK
  • Drug Drug Interaction
  • PBPKPlus™
  • ADMET Predictor®
  • Additional Dosage Routes
  • Metabolism & Transporter
  • Biologics
  • Optimization
  • PDPlus™
  • PKPlus™
  • IVIVCPlus™

Industry-leading PBBM/PBPK modeling and simulation platform that simulates all major dosing routes and drug-drug interactions (DDI) in virtual animal and human populations.

  • Learn More
  • Schedule a Demo

A module that allows you to predict mechanistic and static DDIs among drugs and metabolites.

  • Learn More
  • Schedule a Demo

A module that allows for expanded simulation of distribution, elimination and concentrations of compounds throughout the body.

  • Learn More
  • Schedule a Demo

A module that enables you to obtain predictions from the structure of all physicochemical, pharmacokinetic and CYP metabolism kinetic parameters required for PBPK simulations.

  • Learn More
  • Schedule a Demo

A module that allows simulation of mechanistic absorption and disposition through dermal, intraoral, pulmonary, ocular, intramuscular and intraarticular routes.

  • Learn More
  • Schedule a Demo

A module that extends GastroPlus to include nonlinear pharmacokinetics into any compartment, along with metabolite tracking.

  • Learn More
  • Schedule a Demo

A module that simulates the systemic absorption and pharmacokinetics of biologics—for both monoclonal antibodies (mAb) and antibody-drug conjugates (ADCs).

  • Learn More
  • Schedule a Demo

A module that automatically fits key parameters to the data, optimizes study designs and doses, and “deconvolutes” in vivo release profiles to achieve target concentration v. time curves for parents and/or metabolites.

  • Learn More
  • Schedule a Demo

A module that allows you to fit standard pharmacodynamic (PD) models to observed data and to then use the fitted models to predict PD effect changes due to changes in dose, dosage form, and dosing regimens.

  • Learn More
  • Schedule a Demo

A module for rapidly estimating pharmacokinetic (PK) parameters for noncompartmental analysis (NCA), along with 1-, 2-, & 3-compartment PK models from pharmacokinetic studies (IV and/or oral) without the need to run full simulations.

  • Learn More
  • Schedule a Demo

A module that allows you to develop mechanistic and/or traditional correlations (IVIVC) between either in vitro release and in vivo release or in vitro release and absolute bioavailability, then use the correlation to predict plasma concentration-time profiles for formulations with different in vitro release rates or dose strengths.

  • Learn More
  • Schedule a Demo
05. GastroPlus® Publications
Peer-reviewed Publications
View All Publications
Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies
  • December 17, 2024
  • Journal Articles
Advancements in Ocular Modelling and Simulations: Key Considerations and Case…
Khan MS, Murthy A, Ahmed T
  • Read More
  • Click to View
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report
  • December 16, 2024
  • Journal Articles
Current State and New Horizons in Applications of Physiologically Based…
Tannergren C, Arora S, Babiskin A, Borges L, Chatterjee P, Cheng YH, Dallmann A, Govada A, Heimbach T, Hingle M, Kollipara S, Kotzagiorgis E, Lindahl A, Mackie C, Malamatari M, Mitra A, Moody R, Pepin X, Polli J, Raines K, Rullo G, Sanghavi M, Savkur R, Singh R, Sjögren E, Suarez-Sharp S, Thomas S, Veerasingham S, Wei K, Wu F, Xu Y, Yoon M, Rege B
  • Read More
  • Click to View
Predicting Pharmacokinetics of Active Constituents in Spatholobi caulis by Using Physiologically Based Pharmacokinetic Models
  • December 3, 2024
  • Journal Articles
Predicting Pharmacokinetics of Active Constituents in Spatholobi caulis by Using…
Liu X, Du R, Zhang T, Li Y, Li L, Yang Z, Wang Q
  • Read More
  • Click to View
Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development of Bioequivalent Formulation for Mesalamine Enteric Coated Tablet: A Tough Nut to Crack
  • December 2, 2024
  • Journal Articles
Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development…
Kollipara S, Prabhat PK, Saha P, Gupta S, Naidu VR, Ahmed T
  • Read More
  • Click to View
Advancing Systemic Toxicity Risk Assessment: Evaluation of a NAM-based Toolbox Approach
  • December 18, 2024
  • Journal Articles
Advancing Systemic Toxicity Risk Assessment: Evaluation of a NAM-based Toolbox…
Cable S, Baltazar MT, Bunglawala F, Carmichael PL, Contreas L, Dent MP, Houghton J, Kukic P, Malcomber S, Nicol B, Przybylak KR, Punt A, Reynolds GK, Reynolds J, Scott S, Tang D, Middleton AM
  • Read More
  • Click to View
Establishment of Biopredictive Dissolution and Bioequivalence Safe Space Using the Physiologically Based Biopharmaceutics Modeling for Tacrolimus Extended-Release Capsules
  • December 17, 2024
  • Journal Articles
Establishment of Biopredictive Dissolution and Bioequivalence Safe Space Using the…
Bi F, Yuan T, Zhang B, Li J, Lin Y, Yang J
  • Read More
  • Click to View
Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies
  • December 17, 2024
  • Journal Articles
Advancements in Ocular Modelling and Simulations: Key Considerations and Case…
Khan MS, Murthy A, Ahmed T
  • Read More
  • Click to View
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report
  • December 16, 2024
  • Journal Articles
Current State and New Horizons in Applications of Physiologically Based…
Tannergren C, Arora S, Babiskin A, Borges L, Chatterjee P, Cheng YH, Dallmann A, Govada A, Heimbach T, Hingle M, Kollipara S, Kotzagiorgis E, Lindahl A, Mackie C, Malamatari M, Mitra A, Moody R, Pepin X, Polli J, Raines K, Rullo G, Sanghavi M, Savkur R, Singh R, Sjögren E, Suarez-Sharp S, Thomas S, Veerasingham S, Wei K, Wu F, Xu Y, Yoon M, Rege B
  • Read More
  • Click to View
Predicting Pharmacokinetics of Active Constituents in Spatholobi caulis by Using Physiologically Based Pharmacokinetic Models
  • December 3, 2024
  • Journal Articles
Predicting Pharmacokinetics of Active Constituents in Spatholobi caulis by Using…
Liu X, Du R, Zhang T, Li Y, Li L, Yang Z, Wang Q
  • Read More
  • Click to View
Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development of Bioequivalent Formulation for Mesalamine Enteric Coated Tablet: A Tough Nut to Crack
  • December 2, 2024
  • Journal Articles
Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development…
Kollipara S, Prabhat PK, Saha P, Gupta S, Naidu VR, Ahmed T
  • Read More
  • Click to View
Advancing Systemic Toxicity Risk Assessment: Evaluation of a NAM-based Toolbox Approach
  • December 18, 2024
  • Journal Articles
Advancing Systemic Toxicity Risk Assessment: Evaluation of a NAM-based Toolbox…
Cable S, Baltazar MT, Bunglawala F, Carmichael PL, Contreas L, Dent MP, Houghton J, Kukic P, Malcomber S, Nicol B, Przybylak KR, Punt A, Reynolds GK, Reynolds J, Scott S, Tang D, Middleton AM
  • Read More
  • Click to View
Establishment of Biopredictive Dissolution and Bioequivalence Safe Space Using the Physiologically Based Biopharmaceutics Modeling for Tacrolimus Extended-Release Capsules
  • December 17, 2024
  • Journal Articles
Establishment of Biopredictive Dissolution and Bioequivalence Safe Space Using the…
Bi F, Yuan T, Zhang B, Li J, Lin Y, Yang J
  • Read More
  • Click to View
Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies
  • December 17, 2024
  • Journal Articles
Advancements in Ocular Modelling and Simulations: Key Considerations and Case…
Khan MS, Murthy A, Ahmed T
  • Read More
  • Click to View
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report
  • December 16, 2024
  • Journal Articles
Current State and New Horizons in Applications of Physiologically Based…
Tannergren C, Arora S, Babiskin A, Borges L, Chatterjee P, Cheng YH, Dallmann A, Govada A, Heimbach T, Hingle M, Kollipara S, Kotzagiorgis E, Lindahl A, Mackie C, Malamatari M, Mitra A, Moody R, Pepin X, Polli J, Raines K, Rullo G, Sanghavi M, Savkur R, Singh R, Sjögren E, Suarez-Sharp S, Thomas S, Veerasingham S, Wei K, Wu F, Xu Y, Yoon M, Rege B
  • Read More
  • Click to View
Predicting Pharmacokinetics of Active Constituents in Spatholobi caulis by Using Physiologically Based Pharmacokinetic Models
  • December 3, 2024
  • Journal Articles
Predicting Pharmacokinetics of Active Constituents in Spatholobi caulis by Using…
Liu X, Du R, Zhang T, Li Y, Li L, Yang Z, Wang Q
  • Read More
  • Click to View
Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development of Bioequivalent Formulation for Mesalamine Enteric Coated Tablet: A Tough Nut to Crack
  • December 2, 2024
  • Journal Articles
Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development…
Kollipara S, Prabhat PK, Saha P, Gupta S, Naidu VR, Ahmed T
  • Read More
  • Click to View
Ready to get started?

Sign-up for a free evaluation or schedule a meeting with one of our experts!

Questions? Email info@simulations-plus.com

Discuss my project needs with an expert
Schedule a software demo
Join our newsletter
Software
  • GastroPlus®
  • MonolixSuite™
  • ADMET Predictor®
  • DILIsym®
  • DDDPlus™
  • NAFLDsym®
  • MembranePlus™
  • OBESITYsym™
  • PKanalix®
  • Simulx®
  • IPFsym®
  • ILDsym®
  • MITOsym®
  • MedChem Designer™
  • QSP Software
  • Pro-ficiency Performance Management
  • Panorama KOL Insights Engine
Services
  • Early Drug Discovery
  • Physiologically Based Pharmacokinetics (PBPK)
  • Quantitative Systems Pharmacology (QSP)
  • Clinical Pharmacology & Pharmacometrics (CPP)
  • Pro-ficiency | Adaptive Learning & Insights (ALI)
  • Medical Communications Services
  • Concierge
  • Training and Workshops
Resource Center
  • Blog
  • Journal Articles
  • Flyers
  • Posters
  • Presentations
  • Press Releases
  • Videos
  • White Papers
  • Webinars
Investors
  • Board of Directors
  • Environmental, Social and Governance (ESG)
  • Latest Presentations
  • Press Releases
  • SEC Filings
  • Shareholder Information
  • Corporate Development Initiative
About
  • Simulations Plus
  • Contact
  • Careers
  • Leadership
  • Partners and Collaborators
  • Privacy Notice
  • Cookie Notice
  • Vision, Mission & Values
  • FCOI Policy
Support
  • Customer Portal
  • Datasheets
  • Software Installation
  • Contact Support
Simulations Plus
  • GastroPlus
  • Copyright © 2025 Simulations Plus. All Rights Reserved.
    • Privacy Notice
    • Sitemap
    • Terms of Use
    • Cookie Settings
This website uses cookies
We use cookies to enhance your browsing experience and analyze our traffic. To learn more about our use of cookies and other tracking technologies, please see our Cookie Notice and our Privacy Notice. By clicking “Accept All,” you consent to such use by us of cookies and other tracking technologies. To learn more about your privacy rights and our personal data practices, please see our Privacy Notice.
Accept All Reject AllCookie Settings
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. For more information on use of cookies or similar tracking technologies on our website: View our Cookie Notice. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept